Koeglsperger Thomas, Palleis Carla, Hell Franz, Mehrkens Jan H, Bötzel Kai
Department of Neurology, Ludwig Maximilians University, Munich, Germany.
Department of Translational Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Front Neurol. 2019 May 21;10:410. doi: 10.3389/fneur.2019.00410. eCollection 2019.
Deep brain stimulation (DBS) has become the treatment of choice for advanced stages of Parkinson's disease, medically intractable essential tremor, and complicated segmental and generalized dystonia. In addition to accurate electrode placement in the target area, effective programming of DBS devices is considered the most important factor for the individual outcome after DBS. Programming of the implanted pulse generator (IPG) is the only modifiable factor once DBS leads have been implanted and it becomes even more relevant in cases in which the electrodes are located at the border of the intended target structure and when side effects become challenging. At present, adjusting stimulation parameters depends to a large extent on personal experience. Based on a comprehensive literature search, we here summarize previous studies that examined the significance of distinct stimulation strategies for ameliorating disease signs and symptoms. We assess the effect of adjusting the stimulus amplitude (A), frequency (f), and pulse width (pw) on clinical symptoms and examine more recent techniques for modulating neuronal elements by electrical stimulation, such as interleaving (Medtronic®) or directional current steering (Boston Scientific®, Abbott®). We thus provide an evidence-based strategy for achieving the best clinical effect with different disorders and avoiding adverse effects in DBS of the subthalamic nucleus (STN), the ventro-intermedius nucleus (VIM), and the globus pallidus internus (GPi).
深部脑刺激(DBS)已成为帕金森病晚期、药物难治性特发性震颤以及复杂节段性和全身性肌张力障碍的首选治疗方法。除了将电极准确放置在目标区域外,DBS设备的有效程控被认为是DBS术后个体疗效的最重要因素。一旦植入DBS电极,植入式脉冲发生器(IPG)的程控是唯一可调节的因素,在电极位于预期目标结构边界以及出现具有挑战性的副作用的情况下,这一点变得更加重要。目前,刺激参数的调整在很大程度上依赖个人经验。基于全面的文献检索,我们在此总结了以往研究,这些研究探讨了不同刺激策略对改善疾病体征和症状的意义。我们评估调整刺激幅度(A)、频率(f)和脉宽(pw)对临床症状的影响,并研究通过电刺激调节神经元成分的最新技术,如交错刺激(美敦力公司)或定向电流控制(波士顿科学公司、雅培公司)。因此,我们提供了一种基于证据的策略,以在不同疾病中实现最佳临床效果,并避免丘脑底核(STN)、腹中间核(VIM)和苍白球内侧核(GPi)DBS中的不良反应。